Blast transformation and fibrotic progression in polycythemia vera and essential thrombocythemia: a literature review of incidence and risk factors

por Cerquozzi, S, Tefferi, A
Publicado 2015

Clinical role of obinutuzumab in the treatment of naive patients with chronic lymphocytic leukemia

por Cerquozzi, Sonia, Owen, Carolyn
Publicado 2015

Blastic plasmacytoid dendritic cell neoplasm: challenges and future prospects

por Trottier, Amy M, Cerquozzi, Sonia, Owen, Carolyn J
Publicado 2017

Iliac Vein Compression Syndrome in an Active and Healthy Young Female

por Cerquozzi, Sonia, Pineo, Graham F., Wong, Jason K., Valentine, Karen A.
Publicado 2012

The eIF4G homolog DAP5/p97 supports the translation of select mRNAs during endoplasmic reticulum stress

por Lewis, Stephen M., Cerquozzi, Sonia, Graber, Tyson E., Ungureanu, Nicoleta Hosszu, Andrews, Meghan, Holcik, Martin
Publicado 2008

Prognostic impact of bone marrow fibrosis in polycythemia vera: validation of the IWG-MRT study and additional observations

por Barraco, D, Cerquozzi, S, Hanson, C A, Ketterling, R P, Pardanani, A, Gangat, N, Tefferi, A
Publicado 2017

Risk factors for arterial versus venous thrombosis in polycythemia vera: a single center experience in 587 patients

por Cerquozzi, S., Barraco, D., Lasho, T., Finke, C., Hanson, C. A., Ketterling, R. P., Pardanani, A., Gangat, N., Tefferi, A.
Publicado 2017

Patterns of Ruxolitinib Therapy Failure and Its Management in Myelofibrosis: Perspectives of the Canadian Myeloproliferative Neoplasm Group

por Gupta, Vikas, Cerquozzi, Sonia, Foltz, Lynda, Hillis, Christopher, Devlin, Rebecca, Elsawy, Mahmoud, Grewal, Kuljit, Hamm, Caroline, McNamara, Caroline, Sirhan, Shireen, Leber, Brian
Publicado 2020

S214: DISEASE-MODIFYING ACTIVITY OF NAVTEMADLIN (NVTM) CORRELATED WITH SURVIVAL OUTCOMES IN JANUS KINASE INHIBITOR (JAKI) RELAPSED OR REFRACTORY (R/R) MYELOFIBROSIS (MF) PATIENTS (...

por Vachhani, Pankit, Perkins, Andrew, Mascarenhas, John, Al-Ali, Haifa Kathrin, Kiladjian, Jean-Jacques, Cerquozzi, Sonia, Dybko, Jaroslaw, Delgado, Regina Garcia, Rivas, Jesus Hernández, Hebart, Holger, Huang, Zhuying, Krejsa, Cecile, Qamoos, Hope, Mcgreivy, Jesse, Rothbaum, Wayne P., Verstovsek, Srdan, Vannucchi, Alessandro
Publicado 2023

P1017: REDUCTIONS IN INDOLENT SYSTEMIC MASTOCYTOSIS BIOMARKER BURDEN WITH AVAPRITINIB IN THE REGISTRATIONAL, DOUBLE-BLIND PLACEBO-CONTROLLED PIONEER TRIAL

por Gotlib, Jason, Castells, Mariana, Oude Elberink, Hanneke, Siebenhaar, Frank, Hartmann, Karin, Broesby-Olsen, Sigurd, George, Tracy I., Panse, Jens, Alvarez-Twose, Ivan, Radia, Deepti, Tashi, Tsewang, Bulai Livideanu, Cristina, Sabato, Vito, Van Daele, Paul, Cerquozzi, Sonia, Dybedal, Ingunn, Reiter, Andreas, Ustun, Celalettin, Schafhausen, Philippe, Bose, Prithviraj, Deangelo, Daniel J., Rein, Lindsay, Vachhani, Pankit, Triggiani, Massimo, Rafferty, Mark, Butt, Nauman, Oh, Stephen, Wortmann, Friederike, Ungerstedt, Johanna, Taparia, Minakshi, Kuykendall, Andrew T., Arana Yi, Cecilia, Mattsson, Mattias, Shomali, William, Giannetti, Matthew, Bidollari, Ilda, Lin, Hui-Min, Scherber, Robyn, Roche, Maria, Akin, Cem, Maurer, Marcus
Publicado 2023